Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis).
Gargiulo L, Ibba L, Malagoli P, Balato A, Bardazzi F, Burlando M, Carrera CG, Damiani G, Dapavo P, Dini V, Gaiani FM, Girolomoni G, Guarneri C, Lasagni C, Loconsole F, Marzano AV, Megna M, Mercuri SR, Travaglini M, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: dini v. Front Immunol. 2024 Jan 11;14:1341708. doi: 10.3389/fimmu.2023.1341708. eCollection 2023. Front Immunol. 2024. PMID: 38274801 Free PMC article.
Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity.
Chiricozzi A, Raimondo A, Lembo S, Fausti F, Dini V, Costanzo A, Monfrecola G, Balato N, Ayala F, Romanelli M, Balato A. Chiricozzi A, et al. Among authors: dini v. Expert Rev Clin Immunol. 2016 Dec;12(12):1299-1308. doi: 10.1080/1744666X.2016.1201423. Epub 2016 Jun 27. Expert Rev Clin Immunol. 2016. PMID: 27322922 Review.
Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study.
Marzano AV, Genovese G, Casazza G, Moltrasio C, Dapavo P, Micali G, Sirna R, Gisondi P, Patrizi A, Dini V, Bianchini D, Bianchi L, Fania L, Prignano F, Offidani A, Atzori L, Bettoli V, Cannavò SP, Venturini M, Bongiorno MR, Costanzo A, Fabbrocini G, Peris K. Marzano AV, et al. Among authors: dini v. Br J Dermatol. 2021 Jan;184(1):133-140. doi: 10.1111/bjd.18983. Epub 2020 Apr 13. Br J Dermatol. 2021. PMID: 32119111 Free article.
Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscore.
Marzano AV, Chiricozzi A, Giovanardi G, Argenziano G, Bettoli V, Bianchi L, Dapavo P, Dini V, Fabbrocini G, Micali G, Offidani AM, Potenza C, Prignano F, Gualberti G, Saragaglia V, Rongioletti F. Marzano AV, et al. Among authors: dini v. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1815-1821. doi: 10.1111/jdv.16328. Epub 2020 May 12. J Eur Acad Dermatol Venereol. 2020. PMID: 32119143 Free PMC article.
Characterization of Hidradenitis Suppurativa Phenotypes: A Multidimensional Latent Class Analysis of the National Italian Registry IRHIS.
Cazzaniga S, Pezzolo E, Bettoli V, Abeni D, Marzano AV, Patrizi A, Atzori L, Fabbrocini G, Offidani A, Lasagni C, Dini V, Caproni M, Cannavò SP, Naldi L. Cazzaniga S, et al. Among authors: dini v. J Invest Dermatol. 2021 May;141(5):1236-1242.e1. doi: 10.1016/j.jid.2020.08.032. Epub 2020 Oct 21. J Invest Dermatol. 2021. PMID: 33098826 Free article.
Hidradenitis suppurativa and adalimumab in the COVID-19 era.
Marzano AV, Moltrasio C, Genovese G, Muratori S, Dapavo P, Fabbrocini G, Patrizi A, Sechi A, Micali G, Pellegrino M, Gisondi P, Dini V, Bianchi L, Fania L, Offidani A, Prignano F, Atzori L, Miraglia E, Cannavò SP, Bettoli V, Stingeni L, Balestri R, Venturini M, Peris K. Marzano AV, et al. Among authors: dini v. Eur J Dermatol. 2020 Dec 1;30(6):748-749. doi: 10.1684/ejd.2020.3927. Eur J Dermatol. 2020. PMID: 33337329 Free PMC article. No abstract available.
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations.
Gisondi P, Talamonti M, Chiricozzi A, Piaserico S, Amerio P, Balato A, Bardazzi F, Calzavara Pinton P, Campanati A, Cattaneo A, Dapavo P, De Simone C, Dini V, Fargnoli MC, Flori ML, Galluzzo M, Guarneri C, Lasagni C, Loconsole F, Lo Schiavo A, Malagoli P, Malara G, Mercuri SR, Musumeci ML, Naldi L, Papini M, Parodi A, Potenza C, Prignano F, Rongioletti F, Stingeni L, Tiberio R, Venturini M, Bianchi L, Costanzo A, Cusano F, Girolomoni G, Offidani AM, Peris K. Gisondi P, et al. Among authors: dini v. Dermatol Ther (Heidelb). 2021 Feb;11(1):235-252. doi: 10.1007/s13555-020-00475-8. Epub 2021 Jan 11. Dermatol Ther (Heidelb). 2021. PMID: 33426634 Free PMC article.
228 results